FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911143112> ?p ?o ?g. }

• W2911143112 endingPage "175" @default.
• W2911143112 startingPage "166" @default.
• W2911143112 abstract "OBJECTIVES Striae distensae are linear atrophic dermal scars. Despite several currently available therapeutic modalities, no consistently effective therapies have been established. This study aimed to evaluate and compare the efficacy of topical recombinant human epidermal growth factor (rhEGF) and ablative fractional carbon dioxide (CO2 ) laser (AFXL) versus ablative fractional CO2 laser and topical Aloe vera gel in treating striae alba. METHODS A total of 24 participants with striae alba were enrolled. Patients' striae were divided into the left and right sides. Participants were treated with fractional CO2 laser on both sides for three sessions at 4-week intervals. Immediately after the laser treatment, each side of the striae was randomly assigned to either rhEGF or Aloe vera gel treatment. Patients were required to apply the medication twice daily up to 1 month after the last laser treatment session. Texture, average melanin, and melanin variation were assessed at pretreatment, 1 month after the first, second, and third treatments, and 6 months after the last treatment. Participants were asked to complete a self-administered questionnaire. Nine participants underwent skin biopsies of the nontreated and treated striae, which were obtained from each treated side. RESULTS Both sides of the treatment area showed significant improvement in texture starting from 1-month follow-up, which sustained up to 6 months after the final treatment, albeit without statistically significant difference between the rhEGF- and Aloe vera-treated sides (P < 0.001, 0.003, and 0.002 for the AFXL-rhEGF-treated side and P = 0.024, 0.001, and 0.001 for the AFXL-Aloe-treated side at 1 month after the first treatment, 1 month after the last treatment, and 6 months after the last treatment, respectively). Participants expressed satisfaction with the AFXL-rhEGF-treated side, which showed significantly greater marked improvement (at 50%) than the AFXL-Aloe-treated side at 6 months after the final treatment (P = 0.034). Post-inflammatory hyperpigmentation (PIH) occurred in 95.8% of participants, which decreased after 6 months compared with baseline. Both treatments improved melanin variation at 6 months after the final treatment, although without significant difference from pretreatment between both groups. Skin biopsy revealed a statistically significant increase in epidermal thickness and decrease in elastic fragmentation in both groups. CONCLUSION AFXL-rhEGF and AFXL-Aloe significantly improved the striae surface texture. PIH was the most common side effect, which improved at 6 months. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc." @default.
• W2911143112 created "2019-01-25" @default.
• W2911143112 creator A5017054364 @default.
• W2911143112 creator A5049407614 @default.
• W2911143112 creator A5073001513 @default.
• W2911143112 date "2019-01-06" @default.
• W2911143112 modified "2023-09-23" @default.
• W2911143112 title "Comparison between topical recombinant human epidermal growth factor and <i>Aloe vera</i> gel in combination with ablative fractional carbon dioxide laser as treatment for striae alba: A randomized double‐blind trial" @default.
• W2911143112 cites W1642792204 @default.
• W2911143112 cites W1765289887 @default.
• W2911143112 cites W1831621370 @default.
• W2911143112 cites W1866852764 @default.
• W2911143112 cites W1901798279 @default.
• W2911143112 cites W1973186585 @default.
• W2911143112 cites W2001306312 @default.
• W2911143112 cites W2010211640 @default.
• W2911143112 cites W2012347898 @default.
• W2911143112 cites W2018612646 @default.
• W2911143112 cites W2028839182 @default.
• W2911143112 cites W2030015590 @default.
• W2911143112 cites W2032324617 @default.
• W2911143112 cites W2044466003 @default.
• W2911143112 cites W2044942006 @default.
• W2911143112 cites W2047091154 @default.
• W2911143112 cites W2056816464 @default.
• W2911143112 cites W2058520611 @default.
• W2911143112 cites W2060845746 @default.
• W2911143112 cites W2063786570 @default.
• W2911143112 cites W2078585128 @default.
• W2911143112 cites W2081159973 @default.
• W2911143112 cites W2088008031 @default.
• W2911143112 cites W2096032824 @default.
• W2911143112 cites W2106384108 @default.
• W2911143112 cites W2107395488 @default.
• W2911143112 cites W2111757015 @default.
• W2911143112 cites W2122265366 @default.
• W2911143112 cites W2123757395 @default.
• W2911143112 cites W2128422446 @default.
• W2911143112 cites W2133212411 @default.
• W2911143112 cites W2154782524 @default.
• W2911143112 cites W2158120276 @default.
• W2911143112 cites W2158731897 @default.
• W2911143112 cites W2275986086 @default.
• W2911143112 cites W2278262184 @default.
• W2911143112 cites W2294137052 @default.
• W2911143112 cites W2299923017 @default.
• W2911143112 cites W2312619242 @default.
• W2911143112 cites W2553767262 @default.
• W2911143112 cites W2586264905 @default.
• W2911143112 cites W2604488765 @default.
• W2911143112 cites W2742857983 @default.
• W2911143112 cites W2770509425 @default.
• W2911143112 cites W2781934381 @default.
• W2911143112 cites W3010297583 @default.
• W2911143112 cites W4379277985 @default.
• W2911143112 cites W567547588 @default.
• W2911143112 doi "https://doi.org/10.1002/lsm.23052" @default.
• W2911143112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30614013" @default.
• W2911143112 hasPublicationYear "2019" @default.
• W2911143112 type Work @default.
• W2911143112 sameAs 2911143112 @default.
• W2911143112 citedByCount "16" @default.
• W2911143112 countsByYear W29111431122019 @default.
• W2911143112 countsByYear W29111431122020 @default.
• W2911143112 countsByYear W29111431122021 @default.
• W2911143112 countsByYear W29111431122022 @default.
• W2911143112 countsByYear W29111431122023 @default.
• W2911143112 crossrefType "journal-article" @default.
• W2911143112 hasAuthorship W2911143112A5017054364 @default.
• W2911143112 hasAuthorship W2911143112A5049407614 @default.
• W2911143112 hasAuthorship W2911143112A5073001513 @default.
• W2911143112 hasConcept C120665830 @default.
• W2911143112 hasConcept C121332964 @default.
• W2911143112 hasConcept C141071460 @default.
• W2911143112 hasConcept C142724271 @default.
• W2911143112 hasConcept C16005928 @default.
• W2911143112 hasConcept C168563851 @default.
• W2911143112 hasConcept C19617505 @default.
• W2911143112 hasConcept C204787440 @default.
• W2911143112 hasConcept C27081682 @default.
• W2911143112 hasConcept C2776829320 @default.
• W2911143112 hasConcept C2779404486 @default.
• W2911143112 hasConcept C2780902700 @default.
• W2911143112 hasConcept C2991744798 @default.
• W2911143112 hasConcept C509974204 @default.
• W2911143112 hasConcept C520434653 @default.
• W2911143112 hasConcept C556039675 @default.
• W2911143112 hasConcept C71924100 @default.
• W2911143112 hasConceptScore W2911143112C120665830 @default.
• W2911143112 hasConceptScore W2911143112C121332964 @default.
• W2911143112 hasConceptScore W2911143112C141071460 @default.
• W2911143112 hasConceptScore W2911143112C142724271 @default.
• W2911143112 hasConceptScore W2911143112C16005928 @default.
• W2911143112 hasConceptScore W2911143112C168563851 @default.
• W2911143112 hasConceptScore W2911143112C19617505 @default.
• W2911143112 hasConceptScore W2911143112C204787440 @default.
• W2911143112 hasConceptScore W2911143112C27081682 @default.
• W2911143112 hasConceptScore W2911143112C2776829320 @default.

• next